₹0
9M+ Happy Customers
100% Authentic
Quality Checked Products| ALTERNATE BRANDS |
| Galvus 50mg Tablet 15'S Prescription Diabetes Rx required MRP ₹ 327.50 Get this at ₹ 262.00 > 15 Tablet(s) in a Strip Mkt: Novartis Healthcare Pvt Ltd |
| JALRA 50mg Tablet 15's Prescription Diabetes Rx required MRP ₹ 330.00 Get this at ₹ 264.00 > 15 Tablet(s) in a Strip Mkt: Usv Private Ltd |
| ZOMELIS 50mg Tablet 15's Prescription Diabetes Rx required MRP ₹ 163.35 Get this at ₹ 130.68 > 15 Tablet(s) in a Strip Mkt: Eris Lifesciences Ltd |
Frequently bought together
Introduction About VIDAGLO 50MG TABLET
VIDAGLO 50MG TABLET is used in adults to manage type 2 diabetes which helps to control the blood sugar levels when diet and exercise becomes insufficient to control the disease. It contains Vildagliptin which belongs to group of medicines called Oral Anti-diabetics.
Take VIDAGLO 50MG TABLET as advised by your physician. Do not crush or chew VIDAGLO 50MG TABLET. Swallow the medicine with a glass of water.
Along management with VIDAGLO 50MG TABLET, your doctor might advise you to follow the diet and/or exercise which is beneficial. Avoid consumption of alcohol because it might lead to low blood glucose levels. Before taking VIDAGLO 50MG TABLET, inform your doctor if you are on dialysis or have diabetic ketoacidosis (serious complication of diabetes), pancreatic disease, heart failure and liver or kidney disease.
VIDAGLO 50MG TABLET is not recommended for use in pregnant and breast-feeding women, which is also not recommended for use in children and adolescents (aged below 18 years). It should be used with caution in elderly patients (aged 65 years and above).
The side effects of taking VIDAGLO 50MG TABLET are dizziness, headache, joint pain and constipation.
Uses Of VIDAGLO 50MG TABLET
How VIDAGLO 50MG TABLET Works
VIDAGLO 50MG TABLET controls blood glucose level by acting on the pancreas to produce more insulin and less glucagon which leads to low production of blood sugar levels resulting in controlled blood glucose levels.
How to use VIDAGLO 50MG TABLET
- Take VIDAGLO 50MG TABLET as advised by your physician.
- Do not crush or chew VIDAGLO 50MG TABLET.
- Swallow the medicine with a glass of water.
- Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Side Effects Of VIDAGLO 50MG TABLET
Common Side Effects of VIDAGLO 50MG TABLET:
- Dizziness
- Headache
- Blurred vision
- Constipation
- Nausea, vomiting
- Diarrhea
- rashes
Stop taking VIDAGLO 50MG TABLET and contact your doctor immediately if you experience any of the following side effects:
- Signs of liver disease (hepatitis) such as loss of appetite or dark-colored urine, yellow skin and eyes, nausea
- Signs of inflammation of the pancreas such as severe and persistent pain in the abdomen (stomach area), nausea and vomiting
Warning & Precautions
Pregnancy
ContraindicatedVIDAGLO 50MG TABLET is not recommended for use in pregnant women.
Breastfeeding
ContraindicatedVIDAGLO 50MG TABLET is not recommended for use in breastfeeding women or women who plan to breast-feed.
Driving and Using Machines
Use with CautionDo not drive or operate any machines if you feel dizziness after taking VIDAGLO 50MG TABLET.
Alcohol
Consult your doctorAvoid consumption of alcohol while taking VIDAGLO 50MG TABLET because it might lead to hypoglycemia (lowering of blood glucose levels).
Kidney
Use with CautionVIDAGLO 50MG TABLET should be used with caution in patients with moderate or severe kidney disease and in patients who are undergoing dialysis.
Liver
Use with CautionVIDAGLO 50MG TABLET should be used with caution in patients with liver disease.
Allergy
ContraindicatedDo not take VIDAGLO 50MG TABLET if you are allergic to Vildagliptin or any other ingredients of this medicine.
Heart Disease
Use with CautionVIDAGLO 50MG TABLET should be used with caution in patients suffering from heart failure.
Use In Pediatrics
ContraindicatedVIDAGLO 50MG TABLET is not recommended for use in children and adolescents up to 18 years of age.
Use In Geriatrics
Use with CautionVIDAGLO 50MG TABLET should be used with caution in elderly patients (aged 65 years and above).
Others
Before taking VIDAGLO 50MG TABLET, inform your doctor if you:
- Have type 1 diabetes (i.e. your body does not produce insulin)
- Have a condition called diabetic ketoacidosis (serious complication of diabetes)
- Have intolerance to certain sugars
- Had or have a disease of the pancreas
Interactions
A. Drug-Drug interactions:
Before taking VIDAGLO 50MG TABLET, inform your doctor if you are taking any of the following medicines:
- Oral antidiabetics (medicine used to manage type 2 diabetes) Ex. sulphonylureas such as gliclazide, glipizide
- Digoxin (used to manage heart failure)
- Warfarin (used to manage blood clot)
- Cardiac drugs (such as captopril, enalapril, fosinopril)
- Simvastatin (used to reduce high cholesterol levels)
- Thiazides or other diuretics (medicines used to manage high blood pressure) Ex. chlorothiazide, chlorthalidone, hydrochlorothiazide
- Corticosteroids (used to manage inflammation) Ex. prednisolone
- Certain medicines affecting nervous system such as antidepressants Ex. clomipramine, amitriptyline
- Thyroid medicines (used to lower thyroid levels) Ex. levothyroxine
Over dosage:
If you or anyone else accidentally takes too much of VIDAGLO 50MG TABLET, consult your doctor immediately or visit the nearby hospital. Overdosage symptoms of VIDAGLO 50MG TABLET are muscle pain, mild and transient paraesthesia (burning and prickling sensation in hands and legs), fever, oedema (swelling in arms and legs) and laboratory abnormalities such as transient increase in lipase levels, increases in creatine phosphokinase (CPK), aspartate aminotransferase (AST), C-reactive protein (CRP) and myoglobin levels.
Synopsis
| Drug | : | Vildagliptin |
| Pharmacological Category | : | Dipeptidyl peptidase-4 (DPP-4) inhibitors |
| Therapeutic Indication | : | Type II diabetes mellitus |
| Dosage Forms | : | Tablet |
More Information
FAQs About VIDAGLO 50MG TABLET
Q: Can VIDAGLO 50MG TABLET be used to manage diabetes mellitus?
A: Yes, VIDAGLO 50MG TABLET lowers blood glucose levels and it is specifically used to manage type II diabetes mellitus which is a medical condition where the body does not make enough insulin or if the produced insulin that the body makes is not optimal leading to increased blood glucose levels in the body. Consult your doctor before taking VIDAGLO 50MG TABLET.
Q: Can I take VIDAGLO 50MG TABLET along with other hypoglycemic drugs like metformin or glimepiride?
A: Using VIDAGLO 50MG TABLET along with other hypoglycemic drugs like metformin, glimepiride may drastically lower your blood glucose levels. So, be cautious and inform your doctor before taking any other anti-diabetic medicines.
Q: Does taking VIDAGLO 50MG TABLET cause weight gain?
A: No, VIDAGLO 50MG TABLET has no effect on weight gain. Moreover, these kinds of medicines delay gastric emptying and make you feel satiety (stomach fullness). These further decreases hunger. So, basically VIDAGLO 50MG TABLET has no effect or it does not influence weight gain.
Q: How does VIDAGLO 50MG TABLET work?
A: VIDAGLO 50MG TABLET controls blood glucose level by acting on the pancreas to produce more insulin and less glucagon which leads to low production of blood sugar levels resulting in controlled blood glucose levels.
Q: Does VIDAGLO 50MG TABLET cause dizziness?
A: Yes, VIDAGLO 50MG TABLET may cause dizziness in some individuals. To manage this effect, lie down until dizziness is gone, then get up slowly. Move slowly and carefully, do not hurry. Get adequate rest. Drink plenty of water and other fluids. Avoid coffee, cigarettes, alcohol and drugs. Consult your doctor if the symptom gets worse.
Q: Can VIDAGLO 50MG TABLET be used in children?
A: VIDAGLO 50MG TABLET is not recommended for use in children and adolescents up to 18 years of age.
Q: What does VIDAGLO 50MG TABLET contain?
A: It contains Vildagliptin which belongs to group of medicines called Oral Anti-diabetics.
References
1. KD. Tripathi. Insulin, Oral Hypoglycaemic Drugs and Glucagon. Essentials of medical pharmacology. Seventh edition. 2013. Page-275.
2. B Ahren, A Schweizer, S Dejager, E B Villhauer, B E Dunning, J E Foley. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans. NIH National Library of Medicine. National Center for Biotechnology Information.PubMed.gov. [Revised in September 2011] [Accessed on 16th October 2024] click here
3. Kalyan Kumar Gangopadhyay and Parminder Singh. Consensus Statement on Dose Modifications of Antidiabetic Agents in Patients with Hepatic Impairment. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. [Revised in March 2017] [Accessed on 16th October 2024] click here
4. Novartis Europharm Limited. Electronic Medicines Compendium (EMC) [Revised in August 2023] [Accessed on 16th October 2024] click here
5. Novartis Pharma GmbH. European Medicines Agency (EMA). [Revised in July 2012] [Accessed on 16th October 2024] click here
User Feedback
Author Details
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.
